P. Siyah

c-Myc inhibition is critical for HSC expansion and Rad51 expression

F. Şahin, Fatih Kocabaş, S. Canikyan, 2018, bioRxiv.

c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression.

F. Şahin, Fatih Kocabaş, S. Canikyan, 2019, Current cancer drug targets.

Development of Small Molecule MEIS Inhibitors that modulate HSC activity

Fatih Kocabaş, S. Durdağı, M. Uslu, 2020, bioRxiv.

Development of Small Molecule MEIS Inhibitors that modulate HSC activity

Fatih Kocabaş, S. Durdağı, M. Uslu, 2020, Scientific Reports.

Modulating Cas9 activity for precision gene editing.

Fatih Kocabaş, A. Harvey, M. Uslu, 2021, Progress in molecular biology and translational science.

Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity.

Fatih Kocabaş, S. Durdağı, S. Akgol, 2021, The Biochemical journal.

Identification of Viral OTU-Like Plasmodium Parasite Proteases and Development of Antimalarial DUB Inhibitors

Fatih Kocabaş, S. Durdağı, S. Akgol, 2021 .

Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study

S. Adams, Dariush Moussai, J. Zhong, 2016, Molecular Cancer Therapeutics.